Market Overview:
The global DNA sequencer market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for DNA sequencing in various applications such as molecular biology, evolutionary biology, metagenomics, and medicine. In addition, the growing focus on precision medicine is also contributing to the growth of this market. North America dominates the global DNA sequencer market and is expected to continue its dominance during the forecast period.
Product Definition:
A DNA sequencer is a machine used to determine the order of nucleotide bases in a DNA molecule. The importance of DNA sequencing is that it allows scientists to study the genetic code of organisms and identify mutations that may cause disease.
Emulsion PCR:
PCR is a technique that allows for the amplification of DNA from a single gene, or a few genes. PCR also allows for accurate and precise quantification of target nucleic acid in samples. The technology has been used to detect and measure genetic material in various types of samples such as blood, urine, tissue, hair follicle & oral fluid among others.
Bridge Amplification:
The process of amplifying the signal from a weak signal region is called bridge amplification. It is used in DNA sequencing to improve the sensitivity and accuracy of detection. The technique helps detect single nucleotide polymorphism (SNP) at a higher resolution than conventional PCR methods, which makes it applicable for human genome-based studies as well as genetic testing applications.
Application Insights:
Molecular biology accounted for the largest revenue share in 2016. This is attributed to the rising demand for sequencing solutions and consumables by various companies, research institutes, and hospitals across the world. The introduction of new products with enhanced performance has fueled segment growth over recent years. For instance, in January 2017 Illumina launched a new version of its Genome Analyzer IIx platform that enabled customers to analyze DNA samples in less than 60 minutes at a cost of approximately USD 1,000 per lane.
The evolutionary biology segment is expected to witness lucrative growth during the forecast period owing to an increase in government funding for genetic research studies related with species identification through Sequencing Technology (ST). Moreover, increasing focus on disease-causing genes through ST will boost product adoption further driving revenue generation from 2018 to 2030.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a substantial number of research institutes and universities involved in genomic studies. Moreover, government funding for sequencing-based research is also one of the major factors driving this regional market. For instance, as per an NIH fact sheet published in 2016, around USD X million were awarded to researchers from U.S.
Asia Pacific region is expected to grow at a lucrative rate over the forecast period due to increasing awareness about genetic modification among consumers; therefore resulting into increased demand for non-GMO products from countries such as China and India.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of genetic disorders
- Technological advancements in DNA sequencing technology
- Growing number of research and development activities in the field of genomics and proteomics
- Increasing funding for life sciences research
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Sequencer Market Research Report
By Type
Emulsion PCR, Bridge Amplification, Single-molecule, PCR
By Application
Molecular Biology, Evolutionary Biology, Metagenomics, Medicine, Others
By Companies
Roche, Illumina, Life Technologies, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, Abbott Laboratories, GE Healthcare Life Sciences, Johnson & Johnson, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
187
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global DNA Sequencer Market Report Segments:
The global DNA Sequencer market is segmented on the basis of:
Types
Emulsion PCR, Bridge Amplification, Single-molecule, PCR
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Molecular Biology, Evolutionary Biology, Metagenomics, Medicine, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Illumina
- Life Technologies
- Beckman Coulter
- Pacific Biosciences
- Oxford Nanopore
- Abbott Laboratories
- GE Healthcare Life Sciences
- Johnson & Johnson
- Roche
Highlights of The DNA Sequencer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Emulsion PCR
- Bridge Amplification
- Single-molecule
- PCR
- By Application:
- Molecular Biology
- Evolutionary Biology
- Metagenomics
- Medicine
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Sequencer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A DNA sequencer is a laboratory instrument that can identify the sequence of nucleotides in DNA.
Some of the key players operating in the dna sequencer market are Roche, Illumina, Life Technologies, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, Abbott Laboratories, GE Healthcare Life Sciences, Johnson & Johnson, Roche.
The dna sequencer market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DNA Sequencer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 DNA Sequencer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 DNA Sequencer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the DNA Sequencer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global DNA Sequencer Market Size & Forecast, 2020-2028
4.5.1 DNA Sequencer Market Size and Y-o-Y Growth
4.5.2 DNA Sequencer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Emulsion PCR
5.2.2 Bridge Amplification
5.2.3 Single-molecule
5.2.4 PCR
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Molecular Biology
6.2.2 Evolutionary Biology
6.2.3 Metagenomics
6.2.4 Medicine
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DNA Sequencer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DNA Sequencer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Emulsion PCR
9.6.2 Bridge Amplification
9.6.3 Single-molecule
9.6.4 PCR
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Molecular Biology
9.10.2 Evolutionary Biology
9.10.3 Metagenomics
9.10.4 Medicine
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Emulsion PCR
10.6.2 Bridge Amplification
10.6.3 Single-molecule
10.6.4 PCR
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Molecular Biology
10.10.2 Evolutionary Biology
10.10.3 Metagenomics
10.10.4 Medicine
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Emulsion PCR
11.6.2 Bridge Amplification
11.6.3 Single-molecule
11.6.4 PCR
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Molecular Biology
11.10.2 Evolutionary Biology
11.10.3 Metagenomics
11.10.4 Medicine
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Emulsion PCR
12.6.2 Bridge Amplification
12.6.3 Single-molecule
12.6.4 PCR
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Molecular Biology
12.10.2 Evolutionary Biology
12.10.3 Metagenomics
12.10.4 Medicine
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Emulsion PCR
13.6.2 Bridge Amplification
13.6.3 Single-molecule
13.6.4 PCR
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Molecular Biology
13.10.2 Evolutionary Biology
13.10.3 Metagenomics
13.10.4 Medicine
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DNA Sequencer Market: Competitive Dashboard
14.2 Global DNA Sequencer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Illumina
14.3.3 Life Technologies
14.3.4 Beckman Coulter
14.3.5 Pacific Biosciences
14.3.6 Oxford Nanopore
14.3.7 Abbott Laboratories
14.3.8 GE Healthcare Life Sciences
14.3.9 Johnson & Johnson
14.3.10 Roche
